Immediate Impact

1 by Nobel laureates 51 standout
Sub-graph 1 of 25

Citing Papers

Targeting the tumour vasculature: from vessel destruction to promotion
2024 Standout
Radiolabelling of nanomaterials for medical imaging and therapy
2021 Standout
2 intermediate papers

Works of S. Rosenfeld being referenced

Phase II study of verubulin (MPC-6827) for the treatment of subjects with recurrent glioblastoma naïve to treatment with bevacizumab.
2011
FDG-PET in differentiating lymphoma from nonmalignant central nervous system lesions in patients with AIDS.
1993

Author Peers

Author Last Decade Papers Cites
S. Rosenfeld 120 44 46 106 101 14 339
Kevin Imrie 61 140 36 59 151 16 328
Douglas J. Ellison 79 35 24 19 140 11 374
Kristy M. Walsh 66 108 14 41 148 16 348
L B North 61 82 170 55 167 11 345
Schur Ph 86 12 24 13 104 16 372
Donald W. McCloskey 46 50 92 19 61 13 319
R. Grace 51 68 52 21 125 17 347
J. M. M. Darte 26 49 60 39 75 18 308
Robert Irby 48 21 21 26 25 20 340
L Rivabella 38 56 79 37 36 13 385

All Works

Loading papers...

Rankless by CCL
2026